Journal: Frontiers in Immunology
Article Title: CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling
doi: 10.3389/fimmu.2023.1254697
Figure Lengend Snippet: CXCL4 and CXCL17 bind heparin and heparan sulfate with high capacities. Real-time assessment of CXCL4 and CXCL17 (24–119) binding to immobilized heparin (dp8) and HS as assessed by bio-layer interferometry (BLI). Sensorgrams illustrate the binding associations between streptavidin immobilized biotinylated heparin (A) , or HS (B) , and various equimolar concentrations of CXCL4 and CXCL17. Prepared solutions of chemokine were sampled with BLI (Octet) streptavidin-coated sensors containing bound GAG, for a 1,080-s association phase, and a 1,500-s dissociation phase. The experiment was performed in triplicate with data displayed as wavelength shift (nm) from a single representative sensorgram plot. (C–E) The extent of molecular association of CXCL4 or CXCL17 with heparin or HS at increasing concentrations of chemokine. Measurements were taken of induced wavelength shift (nm), with maximal recorded wavelength shifts for 15.6 nM (C) , 62.5 nM (D) , and 250 nM (E) of chemokine. Data are displayed as mean wavelength shift (nm) + SEM from three independent experiments, and two-way ANOVA with Sidak’s multiple comparison test was performed, and statistical significance is displayed as * p < 0.05.
Article Snippet: Heparin dp8 and heparan sulfate (HS) used in the bio-layer interferometry (BLI) assays were from Iduron (Alderley Edge, UK).
Techniques: Binding Assay, Comparison